Breakthrough Science

Objective

A privately-held biotech in cell therapy research with assets in early pre-clinical stage looking to gather strategic intelligence on the following:

• Objective assessment of the competitive positioning of the company’s porfolio in the context of broader cell therapy landscape

• Early signals of opportunities and risks within ecosystem aligned to company’s development pipeline and portfolio of research

• Informing strategic decision- making for functions including Executive board, R&D and BD on short to long-term initiatives as well as investment, partnership and acquisition targets

Intelligencia's Advantage

Intelligencia’s Breakthrough Science harnesses relevant data from publications, public and private funding, patents, conferences, company filings, and press releases. The platform uses state-of-the- art ML algorithms, such as topic modeling, and enables users to search and contextualize the overall activity. More specifically, users can:

• Review and analyze landscape rapidly including platforms & technologies of interest, targets, indications and companies
• Visualize results and share insights across the organization in real time
• Identify key academic and industry players through cluster analysis
• Systematically assess emerging opportunities ahead of the competition

Impact